Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 1
1976 4
1977 2
1979 1
1980 2
1981 2
1982 1
1983 3
1984 2
1985 1
1986 5
1987 1
1989 5
1990 2
1992 1
1993 3
1994 7
1995 11
1996 5
1997 11
1998 10
1999 9
2000 4
2001 8
2002 5
2003 6
2004 4
2005 7
2006 8
2007 13
2008 13
2009 15
2010 7
2011 7
2012 14
2013 18
2014 18
2015 13
2016 22
2017 17
2018 22
2019 31
2020 11
2021 19
2022 25
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Benign neoplasm of sebaceous gland"
Page 1
Dermoscopy of Adnexal Tumors.
Zaballos P, Gómez-Martín I, Martin JM, Bañuls J. Zaballos P, et al. Dermatol Clin. 2018 Oct;36(4):397-412. doi: 10.1016/j.det.2018.05.007. Epub 2018 Aug 16. Dermatol Clin. 2018. PMID: 30201149 Review.
Cutaneous adnexal tumors include lesions with apocrine, eccrine, follicular, sebaceous, and mixed differentiation. Most are benign and sporadic, although malignant forms are occasionally observed and some cases develop in the setting of inherited syndromes. . …
Cutaneous adnexal tumors include lesions with apocrine, eccrine, follicular, sebaceous, and mixed differentiation. Most are benign …
Sonographic appearance of sebaceous cysts. Our experience and a review of the literature.
Solivetti FM, Desiderio F, Elia F, Guerrisi A, Cota C, Morrone A. Solivetti FM, et al. Int J Dermatol. 2019 Dec;58(12):1353-1359. doi: 10.1111/ijd.14515. Epub 2019 Jun 17. Int J Dermatol. 2019. PMID: 31209860 Review.
Sebaceous cysts are benign enveloped nodules resulting from an obstruction of a hair follicle. ...We decided to reevaluate the sonographic appearance of the last 100 patients with sebaceous cysts that were under our observation through conducting a ret …
Sebaceous cysts are benign enveloped nodules resulting from an obstruction of a hair follicle. ...We decided to reevaluate the …
Molecular pathology of skin adnexal tumours.
Plotzke JM, Adams DJ, Harms PW. Plotzke JM, et al. Histopathology. 2022 Jan;80(1):166-183. doi: 10.1111/his.14441. Histopathology. 2022. PMID: 34197659 Review.
AIMS: Tumours of the cutaneous adnexa arise from, or differentiate towards, structures in normal skin such as hair follicles, sweat ducts/glands, sebaceous glands or a combination of these elements. This class of neoplasms includes benign tumour …
AIMS: Tumours of the cutaneous adnexa arise from, or differentiate towards, structures in normal skin such as hair follicles, sweat ducts/ …
PD-L1 expression in sebaceous carcinomas.
Saliba M, Shaheen M, Hajj RE, Abbas F, Bashir S, Sheikh UN, Mahfouz R, Loya A, Khalifeh I. Saliba M, et al. Cancer Immunol Immunother. 2021 Jul;70(7):1907-1915. doi: 10.1007/s00262-020-02821-3. Epub 2021 Jan 4. Cancer Immunol Immunother. 2021. PMID: 33398391 Free PMC article.
BACKGROUND: Traditional systemic treatments for unresectable, recurrent, and/or advanced sebaceous carcinoma (SC) are ineffective. Tumoral immune microenvironment characterization is essential for considering immune checkpoint inhibitors as a treatment option. ...PD-L1 per …
BACKGROUND: Traditional systemic treatments for unresectable, recurrent, and/or advanced sebaceous carcinoma (SC) are ineffective. Tu …
NECTIN4 expression in sebaceous and sweat gland carcinoma.
Ito T, Hashimoto H, Tanaka Y, Tanegashima K, Murata M, Oda Y, Kaku-Ito Y. Ito T, et al. Eur J Dermatol. 2022 Apr 1;32(2):181-186. doi: 10.1684/ejd.2022.4241. Eur J Dermatol. 2022. PMID: 35866909 English.
BACKGROUND: Sebaceous carcinoma and sweat gland carcinoma (malignant tumours with apocrine and eccrine differentiation) are rare malignant adnexal tumours that differentiate toward sebaceous glands and eccrine and apocrine glands, respectively. …
BACKGROUND: Sebaceous carcinoma and sweat gland carcinoma (malignant tumours with apocrine and eccrine differentiation) are ra …
Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours.
Hellquist H, Paiva-Correia A, Vander Poorten V, Quer M, Hernandez-Prera JC, Andreasen S, Zbären P, Skalova A, Rinaldo A, Ferlito A. Hellquist H, et al. Adv Ther. 2019 Aug;36(8):1950-1974. doi: 10.1007/s12325-019-01007-3. Epub 2019 Jun 17. Adv Ther. 2019. PMID: 31209701 Free PMC article. Review.
INTRODUCTION: A vast increase in knowledge of numerous aspects of malignant salivary gland tumours has emerged during the last decade and, for several reasons, this has not been the case in benign epithelial salivary gland tumours. We have performed a literat …
INTRODUCTION: A vast increase in knowledge of numerous aspects of malignant salivary gland tumours has emerged during the last decade …
Sebaceous Carcinoma of the Eyelid: A Systematic Review and Meta-Analysis.
Desiato VM, Byun YJ, Nguyen SA, Thiers BH, Day TA. Desiato VM, et al. Dermatol Surg. 2021 Jan 1;47(1):104-110. doi: 10.1097/DSS.0000000000002660. Dermatol Surg. 2021. PMID: 33347004
BACKGROUND: Sebaceous carcinoma (SC) of the eyelid is a rare, aggressive malignancy associated with high rates of recurrence, metastasis, and tumor-related mortality. OBJECTIVE: Provide a collective analysis of clinical presentations, management techniques, and outcomes, a …
BACKGROUND: Sebaceous carcinoma (SC) of the eyelid is a rare, aggressive malignancy associated with high rates of recurrence, metasta …
The Role of Podoplanin in Skin Diseases.
Asai J. Asai J. Int J Mol Sci. 2022 Jan 24;23(3):1310. doi: 10.3390/ijms23031310. Int J Mol Sci. 2022. PMID: 35163233 Free PMC article. Review.
Podoplanin is a sialomucin-like type I transmembrane receptor glycoprotein that is expressed specifically in lymphatic vessels, sebaceous glands, and hair follicles in normal skin. However, under pathological conditions podoplanin expression is upregulated in variou …
Podoplanin is a sialomucin-like type I transmembrane receptor glycoprotein that is expressed specifically in lymphatic vessels, sebaceous …
Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
Maloney NJ, Zacher NC, Hirotsu KE, Rajan N, Aasi SZ, Kibbi N. Maloney NJ, et al. J Am Acad Dermatol. 2023 Aug;89(2):269-273. doi: 10.1016/j.jaad.2023.03.032. Epub 2023 Mar 31. J Am Acad Dermatol. 2023. PMID: 37003478
Patients were classified as MTS or non-MTS cases based on a threshold score of 2 on the Mayo MTS risk score. RESULTS: We identified 105 (2.8%) MTS cases and 3677 (97.2%) non-MTS cases. ...On multivariate Cox proportional hazards analysis adjusting for other covariat …
Patients were classified as MTS or non-MTS cases based on a threshold score of 2 on the Mayo MTS risk score. RESULTS: We ident …
Diagnostic Accuracy of GATA6 Immunostaining in Sebaceous Tumors of the Skin.
Oulès B, Deschamps L, Sohier P, Tihy M, Chassac A, Couvelard A, Frouin E, Battistella M. Oulès B, et al. Mod Pathol. 2023 Apr;36(4):100101. doi: 10.1016/j.modpat.2023.100101. Epub 2023 Jan 18. Mod Pathol. 2023. PMID: 36788082
GATA6 transcription factor has been identified as a new marker of the upper folliculosebaceous compartment (lower infundibulum, junctional zone and isthmus, and upper sebaceous gland) in the human skin. We aimed to determine the diagnostic accuracy of GATA6 immunost …
GATA6 transcription factor has been identified as a new marker of the upper folliculosebaceous compartment (lower infundibulum, junctional z …
378 results